Cancer and Family History: Using Genomics for Prevention
Presented on .
The risk factors for cancer are many and varied, and inherited genetic mutations play a major role in 5 to 10% of all cancers. When these mutations are identified early, patients are able to work with their healthcare providers to take crucial steps toward care and treatment. Many of those affected by genetic cancer syndromes don’t know that genetic testing is an option. Both patients and healthcare providers need the resources and education to know when genetic testing is necessary, based on family history and other risk factors.
Cancer genomics programs, including those at CDC, in state and local health departments, and in national organizations, are working together to conduct surveillance and educate the public and healthcare providers about diagnosis and treatment of hereditary cancer syndromes. These programs also aim to assess and reduce barriers to care, ensuring that all those who should receive genetic counseling and testing have access to the appropriate providers.
In this session of Public Health Grand Rounds, you will hear how public health agencies and organizations are evolving in the face of the rapidly growing field of genomics. You will also hear how one woman’s personal experience with a hereditary cancer syndrome led her to become an advocate for patient and provider education.
In this session of Beyond the Data, Dr. John Iskander and Dr. Lisa Richardson discuss how establishing a patient’s family history can help healthcare providers identify genetic mutations that may lead to cancer. Tune in to hear how public health is using education and surveillance to improve identification and treatment of hereditary cancer.
- Lisa Richardson, MD, MPH
- Director, Division of Cancer Prevention and Control
National Center for Chronic Disease Prevention and Health Promotion, CDC
- Debra Duquette, MS, CGC
- Genomics Coordinator and Program Manager
Michigan Department of Health and Human Services
- Lindsay Avner, BA
- Founder and CEO
Bright Pink
- Muin J. Khoury, MD, PhD
- Director, Office of Public Health Genomics,
Division of Public Health Information Dissemination
Center for Surveillance, Epidemiology, and Laboratory Services, CDC
- John Iskander, MD, MPH
- Scientific Director
- Phoebe Thorpe, MD, MPH
- Deputy Scientific Director
- Susan Laird, MSN, RN
- Communications Director
Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!
Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up
Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!
- Presentation Slide Deck [4.3 MB, 63 Pages, HTML]
- Order the Cancer Family History Guide Here [140 KB, 2 pages]
Order the above tool from the Michigan Department of Community Health
CDC Course Code: PHGR10
CPE UAN: 0387-0000-16-004-H04-P
For more information, see Grand Rounds Continuing Education.
Cancer is the second-leading cause of death in the United States. Screening for different cancers helps find these diseases early when they are easiest to treat. Learn about new ways for public health to increase the rate of evidence-based cancer screening, and to decrease screening rate disparities.